|
|
|
%20PRIVATE%20LIMITED%20-%20512143%2029-May-2018_files/image002.jpg){kind=small}
%20PRIVATE%20LIMITED%20-%20512143%2029-May-2018_files/image004.jpg)
%20PRIVATE%20LIMITED%20-%20512143%2029-May-2018_files/image006.gif)
MIRA
INFORM REPORT
|
Report No. : |
512143 |
|
Report Date : |
29.05.2018 |
IDENTIFICATION DETAILS
|
Name : |
MILAN LABORATORIES (INDIA) PRIVATE LIMITED
|
|
|
|
|
Registered
Office : |
303/304, 3rd Floor, Odyssey IT Park, Wagle Estate, MIDC, Thane (West),
Thane-400064, Maharashtra |
|
Tel. No.: |
91-22-25447341 /
25390686 /87 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2017 |
|
|
|
|
Date of
Incorporation : |
26.03.2003 |
|
|
|
|
Com. Reg. No.: |
11-139736 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 19.800 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24230MH2003PTC139736 |
|
|
|
|
IEC No.: |
0392011930 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
PNEM08623G |
|
|
|
|
GSTIN : |
27AADCM5148B1ZQ |
|
|
|
|
PAN No.: [Permanent Account No.] |
AADCM5148B |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Subject is in the business of pharmaceuticals including manufacturing, wholesale, retail, locally and internationally, import and export of tablets, capsules, injections, liquids, packing and any other such products which are necessary in the field of pharmaceuticals. (Registered activity) |
|
|
|
|
No. of Employees
: |
Information declined by the management |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A |
|
Credit Rating |
Explanation |
Rating Comments |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
Maximum Credit Limit : |
USD 1600000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Milan Laboratories (India) Private Limited was incorporated in the
year 2003. It is manufacturer, exporter and importer of tablets,
capsules, injections, liquids, packing and any other such products which are
necessary in the field of pharmaceuticals For the financial year 2017, the company has achieved 4.78% growth in
its revenue along with fair profit margin of 11.94%. The sound financial profile of the company is marked by healthy
networth base along with negligible debt level. The company has decent earning per share (EPS) of INR 76.95 against
the face value (FV) of INR 10. Business is active. Payments seem to be usually correct. In view of aforesaid, the company can be considered for business
dealings at usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low
Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High
Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
SMERA |
|
Rating |
Cash Credit (Suspended) = BB+ |
|
Rating Explanation |
Moderate risk of default. |
|
Date |
18.02.2016 |
|
Rating Agency Name |
SMERA |
|
Rating |
Letter of Credit (Suspended) = A4+ |
|
Rating Explanation |
Minimal degree of safety and very high credit risk. |
|
Date |
18.02.2016 |
Reason for Suspension: Absence of requisite
information.
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction)
LISTING STATUS
Subject’s name is
not listed as a Sick Unit in the publicly available BIFR (Board for Industrial
& Financial Reconstruction) list as of 29.05.2018
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DENIED BY
|
Name : |
Mr. Pushpakant Dongre |
|
Designation : |
Manager |
|
Contact No.: |
91-8097055531 |
|
Date : |
26.05.2018 |
LOCATIONS
|
Registered Office : |
303/304, 3rd
Floor, Odyssey IT Park, Wagle Estate, MIDC, Thane (West), Mumbai – 400064,
Maharashtra, India |
|
Tel. No.: |
91-22-25447341 /
25390686 /87 / 25877736 / 25877733 |
|
|
91-8097055531
(Mr. Pushpakant Dongre - Manager) |
|
Fax No.: |
91-22-25401744 /
25877736 |
|
E-Mail : |
|
|
Website : |
|
|
Location : |
Owned |
|
Locality : |
Industrial |
|
|
|
|
Factory Address : |
Plot No.: 2196/A,
Dahej Sez, Part – II, Dahej, Taluka Vagra, Bharuch - 393130, Gujarat, India |
Note: Factory of the company has been shifted from the Plot No. 35, 36, 63, 64, 65, 67 and 87, Jawahar Co-operative Industrial Estate Limited, Kamothe, Panvel, Navi Mumbai - 401705, Maharashtra, India to the present address.
DIRECTORS
As on 2018
|
Name : |
Mr. Upendra Madan
Deshpande |
|
Designation : |
Director |
|
Address : |
Flat No. 93, 9th
Floor, |
|
Date of Birth/Age : |
30.04.1963 |
|
Qualification : |
Graduate |
|
Date of Appointment : |
26.03.2003 |
|
PAN no.: |
AGMPD2908G |
|
DIN No.: |
02176205 |
|
Voter ID No.: |
MT/10/053/1039017 |
|
|
|
|
Name : |
Mrs. Rohini Rajiv
Dongre |
|
Designation : |
Director |
|
Address : |
703 White Field Hiranandani, Meadows, Thane – 400601, Maharashtra, India |
|
Date of Birth/Age : |
28.10.1959 |
|
Qualification : |
M. Sc. |
|
Date of Appointment : |
26.03.2003 |
|
PAN No.: |
AGRPD2370B |
|
DIN No.: |
01031356 |
|
Voter ID No.: |
MT/10/054/0603343 |
KEY EXECUTIVES
|
Name : |
Mr. Pushpakant Dongre |
|
Designation : |
Manager |
|
|
|
|
Name : |
Mr. Santosh |
|
Designation : |
Accounts Department |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 31.03.2017
|
Names of Shareholders |
No. of Shares |
%age |
|
L.M. Deshpande |
594000 |
30.00 |
|
Upendra Deshpande |
594000 |
30.00 |
|
Rohini Dongre |
594000 |
30.00 |
|
Megha Hajirnis |
198000 |
10.00 |
|
Total |
1980000 |
100.00 |
%20PRIVATE%20LIMITED%20-%20512143%2029-May-2018_files/image008.gif)
Equity Share Break up (Percentage of Total Equity)
As on 29.09.2017
|
Category |
Percentage |
|
Promoter – (Individual/ Hindu Undivided
Family – Indian) |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is in the business of pharmaceuticals including manufacturing, wholesale, retail, locally and internationally, import and export of tablets, capsules, injections, liquids, packing and any other such products which are necessary in the field of pharmaceuticals (Registered activity) |
||||
|
|
|
||||
|
Products : |
|
||||
|
|
|
||||
|
Brand Names : |
Not Divulged |
||||
|
|
|
||||
|
Agencies Held : |
Not Divulged |
||||
|
|
|
||||
|
Exports : |
Not Divulged |
||||
|
|
|
||||
|
Imports : |
Not Divulged |
||||
|
|
|
||||
|
Terms : |
Not Divulged |
PRODUCTION STATUS NOT AVAILABLE
GENERAL INFORMATION
|
Suppliers : |
|
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Customers : |
|
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
No. of Employees : |
Information declined by the management |
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Bankers : |
|
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Facilities : |
|
|
Financial institution : |
SBI Global Factors Limited, 6th Floor, Metropolitan
Building, Bandra-Kurla, Complex, Bandra(East), Mumbai - 400051, Maharashtra,
India |
|
|
|
|
Auditors : |
|
|
Name : |
R. P. Shah and Company Chartered Accountants |
|
Address : |
35, 3rd Floor, Tardeo A C Market Tardeo, Mumbai-400038, Maharashtra, India |
|
PAN N Income-tax PAN of auditor or auditor's firm : |
AALPS7669C |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Associates/Subsidiaries : |
Not Available |
CAPITAL STRUCTURE
As on 31.03.2017
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
2000000 |
Equity Shares |
INR 10/- each |
INR 20.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
1980000 |
Equity Shares |
INR 10/- each |
INR 19.800
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES
OF FUNDS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
19.800 |
19.800 |
19.800 |
|
(b) Reserves & Surplus |
556.152 |
406.168 |
201.998 |
|
(c) Money received against
share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
575.952 |
425.968 |
221.798 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
288.763 |
217.423 |
227.092 |
|
(b) Deferred tax liabilities
(Net) |
(14.597) |
(8.701) |
(4.792) |
|
(c) Other long term
liabilities |
0.550 |
0.550 |
0.200 |
|
(d) long-term provisions |
0.000 |
2.138 |
2.150 |
|
Total
Non-current Liabilities (3) |
274.716 |
211.410 |
224.650 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
99.908 |
56.381 |
70.045 |
|
(b) Trade payables |
252.917 |
212.854 |
175.264 |
|
(c) Other current liabilities |
93.135 |
20.623 |
36.184 |
|
(d) Short-term provisions |
9.993 |
23.252 |
22.142 |
|
Total
Current Liabilities (4) |
455.953 |
313.110 |
303.635 |
|
|
|
|
|
|
TOTAL |
1306.621 |
950.488 |
750.083 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
192.258 |
216.112 |
216.292 |
|
(ii) Intangible Assets |
0.000 |
0.000 |
0.000 |
|
(iii) Capital work-in-progress |
519.258 |
121.226 |
50.939 |
|
(iv) Intangible assets under
development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
0.000 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
27.118 |
22.774 |
59.274 |
|
(e) Other Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total
Non-Current Assets |
738.634 |
360.112 |
326.505 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
7.000 |
1.000 |
0.000 |
|
(b) Inventories |
97.922 |
90.150 |
71.846 |
|
(c) Trade receivables |
261.713 |
211.477 |
223.614 |
|
(d) Cash and cash equivalents |
61.485 |
81.507 |
18.503 |
|
(e) Short-term loans and
advances |
109.320 |
147.474 |
105.709 |
|
(f) Other current assets |
30.547 |
58.768 |
3.906 |
|
Total
Current Assets |
567.987 |
590.376 |
423.578 |
|
|
|
|
|
|
TOTAL |
1306.621 |
950.488 |
750.083 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
SALES |
|
|
|
|
|
Income |
1276.435 |
1340.556 |
1070.667 |
|
|
Other Income |
14.728 |
21.375 |
20.852 |
|
|
TOTAL
|
1291.163 |
1361.931 |
1091.519 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials Consumed |
703.162 |
742.870 |
675.886 |
|
|
Purchases of Stock-in-Trade |
11.482 |
14.960 |
29.212 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
14.728 |
(7.649) |
12.707 |
|
|
Employees benefits expense |
96.532 |
68.190 |
57.127 |
|
|
CSR Expenditure |
2.400 |
1.200 |
0.000 |
|
|
Other expenses |
163.360 |
152.729 |
119.515 |
|
|
TOTAL |
991.664 |
972.300 |
894.447 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
299.499 |
389.631 |
197.072 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
21.434 |
31.133 |
23.266 |
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
278.065 |
358.498 |
173.806 |
|
|
|
|
|
|
|
Less/
Add |
DEPRECIATION/
AMORTISATION |
44.394 |
42.254 |
39.285 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX |
233.671 |
316.244 |
134.521 |
|
|
|
|
|
|
|
Less |
TAX |
81.304 |
109.691 |
46.643 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX |
152.367 |
206.553 |
87.878 |
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
331.168 |
136.998 |
71.421 |
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
Transfer to General Reserve |
10.000 |
10.000 |
20.000 |
|
|
Dividend |
1.980 |
1.980 |
1.980 |
|
|
Tax on Dividend |
0.403 |
0.403 |
0.321 |
|
|
Total
|
12.383 |
12.383 |
22.301 |
|
|
|
|
|
|
|
|
Balance
Carried to the B/S |
471.152 |
331.168 |
136.998 |
|
|
|
|
|
|
|
|
EARNINGS
IN FOREIGN CURRENCY |
|
|
|
|
|
F.O.B. Value of Exports |
1209.631 |
1284.100 |
1062.130 |
|
|
TOTAL
EARNINGS |
1209.631 |
1284.100 |
1062.130 |
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
Raw Materials |
116.211 |
183.785 |
241.398 |
|
|
Components and Stores parts |
3.644 |
4.540 |
0.000 |
|
|
Capital Goods |
0.000 |
0.000 |
3.505 |
|
|
TOTAL
IMPORTS |
119.855 |
188.325 |
244.903 |
|
|
|
|
|
|
|
|
Earnings
/ (Loss) Per Share (INR) |
76.95 |
104.32 |
44.38 |
CURRENT MATURITIES OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Maturities of Long term debt |
0.000 |
0.000 |
0.000 |
|
Net cash flows from (used in) operations |
409.132 |
346.126 |
122.704 |
|
Net cash flows from (used in) operating activities |
308.762 |
231.721 |
170.105 |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Average Collection Days (Sundry Debtors / Income * 365 Days) |
74.84 |
57.58 |
76.23 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry
Debtors) |
4.88 |
6.34 |
4.79 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors
/ Purchases * 365 Days) |
129.18 |
102.52 |
90.73 |
|
|
|
|
|
|
Inventory Turnover (Operating Income
/ Inventories) |
3.06 |
4.32 |
2.74 |
|
|
|
|
|
|
Asset Turnover (Operating Income
/ Net Fixed Assets) |
0.42 |
1.16 |
0.74 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Debt Ratio ((Borrowing + Current Liabilities) / Total
Assets) |
0.57 |
0.56 |
0.71 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability
/ Networth) |
0.67 |
0.64 |
1.34 |
|
|
|
|
|
|
Current Liabilities to Networth (Current
Liabilities / Net Worth) |
0.79 |
0.74 |
1.37 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets
/ Networth) |
1.24 |
0.79 |
1.20 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial
Charges) |
13.97 |
12.52 |
8.47 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Net Profit Margin ((PAT / Sales) *
100) |
% |
11.94 |
15.41 |
8.21 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total
Assets) * 100) |
% |
11.66 |
21.73 |
11.72 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth)
* 100) |
% |
26.45 |
48.49 |
39.62 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Ratio (Current Assets / Current Liabilities) |
1.25 |
1.89 |
1.40 |
|
|
|
|
|
|
Quick Ratio ((Current Assets
– Inventories) / Current Liabilities) |
1.03 |
1.60 |
1.16 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total
Assets) |
0.44 |
0.45 |
0.30 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity
Capital) |
19.63 |
13.83 |
15.01 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current
Assets / Total Current Liabilities) |
1.25 |
1.89 |
1.40 |
Total Liability = Short-term Debt + Long-term
Debt + Current Maturities of Long-term debts
FINANCIAL ANALYSIS
[all figures are
INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Share Capital |
19.800 |
19.800 |
19.800 |
|
Reserves & Surplus |
201.998 |
406.168 |
556.152 |
|
Net
worth |
221.798 |
425.968 |
575.952 |
|
|
|
|
|
|
Long Term borrowings |
227.092 |
217.423 |
288.763 |
|
Short Term borrowings |
70.045 |
56.381 |
99.908 |
|
Current Maturities of Long term debt |
0.000 |
0.000 |
0.000 |
|
Total
borrowings |
297.137 |
273.804 |
388.671 |
|
Debt/Equity
ratio |
1.340 |
0.643 |
0.675 |
%20PRIVATE%20LIMITED%20-%20512143%2029-May-2018_files/image010.gif)
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales
|
1070.667 |
1340.556 |
1276.435 |
|
|
|
25.208 |
(4.783) |
%20PRIVATE%20LIMITED%20-%20512143%2029-May-2018_files/image012.gif)
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales
|
1070.667 |
1340.556 |
1276.435 |
|
Profit |
87.878 |
206.553 |
152.367 |
|
|
8.21% |
15.41% |
11.94% |
%20PRIVATE%20LIMITED%20-%20512143%2029-May-2018_files/image014.gif)
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
Yes |
|
8 |
Designation of contact person |
Yes |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
Yes |
|
12 |
Voter Id Card No. of Proprietor / Partners |
Yes |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
Yes |
|
17 |
Details of sister concerns |
No |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
Yes |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
INTRODUCTION AND
OBJECTIVES
Subject is in the business of pharmaceuticals including manufacturing, wholesale, retail, locally and internationally, import and export of tablets, capsules, injections, liquids, packing and any other such products which are necessary in the field of pharmaceuticals.
Their facility operates in conformance to WHOCGMP, RSAMCC and UKMHRA norms. They are Government recognised ‘Star Export House’ and have received some export performance Awards.
From their strong foundation we inherit a culture that puts ‘Quality’ above everything else. Equipped with the latest machinery, staffed by a highly motivated team of experts, Milan Laboratories (India) Private Limited is your indispensable partner in Pharmaceuticals Services.
At Milan Laboratories (India) Private Limited they believe that a business cannot succeed in a society that fails and therefore it is imperative for business houses to invest in the future by taking part in social building activities. With this objective, the Board of Milan Laboratories (India) Private Limited had in April 2014 decided to approve Corporate Social Responsibility Policy to be in line with the requirements of Section 135 of the Companies Act, 2013.
UNSECURED LOAN
|
Unsecured Loan |
31.03.2017 (INR
in Million) |
31.03.2016 (INR
in Million) |
|
Long-term
Borrowings |
|
|
|
Loans and advances from directors |
147.224 |
140.265 |
|
|
|
|
|
Total |
147.224 |
140.265 |
INDEX OF CHARGES:
|
SNo |
SRN |
Charge Id |
Charge Holder Name |
Date of Creation |
Date of
Modification |
Date of
Satisfaction |
Amount |
Address |
|
1 |
G64393895 |
100135680 |
ICICI BANK LIMITED |
02/11/2017 |
- |
- |
100000000.0 |
ICICI Bank Tower, Near Chakli Circle,Old Padra RoadVadodaraGu390007IN |
|
2 |
C75545947 |
10612230 |
The Hongkong and Shanghai Banking Corporation Limited |
09/05/2015 |
- |
- |
10000000.0 |
India Bulls Finance Center, Tower-3, Ground floor,Senapati Bapat Marg,Elphistone Road westMumbaiMH400013IN |
|
3 |
C51321560 |
10564545 |
DBS Bank Ltd |
16/04/2015 |
- |
- |
16500000.0 |
3rd Floor, Fort House221, Dr. D.N. Road, FortMumbaiMH400001IN |
|
4 |
C74053067 |
10564541 |
DBS Bank Ltd |
16/04/2015 |
16/12/2015 |
- |
100000000.0 |
3rd Floor, Fort HouseDr. D.N. Road, FortMumbaiMH400014IN |
|
5 |
C38962403 |
10540152 |
TATA CAPITAL FINANCIAL SERVICES LIMITED |
18/12/2014 |
- |
- |
5370000.0 |
One Forbes,Dr. V. B. Gandhi Marg, FortMumbaiMH400001IN |
|
6 |
C76052059 |
10377156 |
The Hongkong and Shanghai Banking Corporation Limited |
18/09/2012 |
16/12/2015 |
- |
100000000.0 |
52/60M G Road, FortMumbaiMH400001IN |
|
7 |
B12255881 |
10285507 |
TATA CAPITAL LIMITED |
01/04/2011 |
- |
- |
6010000.0 |
ONE FORBESDR V B GANDHI MARG,FORTMUMBAIMH400001IN |
|
8 |
B42406835 |
10258415 |
ICICI BANK LIMITED |
09/12/2010 |
08/05/2012 |
- |
80000000.0 |
LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN |
|
9 |
G36168300 |
90145497 |
ICICI BANK LIMITED |
05/11/2004 |
27/04/2012 |
10/01/2017 |
87000000.0 |
LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN |
|
10 |
B94256294 |
10359947 |
SBI GLOBAL FACTORS LIMITED |
19/04/2012 |
- |
13/01/2014 |
6000000.0 |
6TH FLOOR, METROPOLITAN BUILDING, BANDRA-KURLACOMPLEX, BANDRA(EAST)MUMBAIMH400051IN |
CONTINGENT
LIABILITIES:
(INR in million)
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
|
Other money for which company is contingently liable |
56.893 |
100.150 |
FIXED ASSETS
- Land
- Buildings
- Plant and equipment
- Furniture and fixtures
- Vehicles
- Office equipment
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 67.82 |
|
|
1 |
INR 90.16 |
|
Euro |
1 |
INR 78.69 |
INFORMATION DETAILS
|
Information
Gathered by : |
SWT |
|
|
|
|
Analysis Done by
: |
VRS |
|
|
|
|
Report Prepared
by : |
SUJ |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.